Adrian Gottschalk - Feb 10, 2022 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Signature
/s /Allan Reine, M.D., Attorney-in-Fact for Adrian Gottschalk
Stock symbol
FHTX
Transactions as of
Feb 10, 2022
Transactions value $
$0
Form type
4
Date filed
2/22/2023, 03:23 PM
Previous filing
Jan 28, 2022
Next filing
Sep 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHTX Common Stock Gift $0 -123K -84.3% $0.00 23K Feb 10, 2022 Direct F1, F2
transaction FHTX Common Stock Gift $0 +123K +37.97% $0.00 449K Feb 10, 2022 See Footnote F1, F2, F3
transaction FHTX Common Stock Other $0 +4.37K +6.94% $0.00 67.4K Oct 25, 2022 Direct F1, F4, F5
transaction FHTX Common Stock Other $0 -4.37K -0.97% $0.00 444K Oct 25, 2022 See Footnote F1, F4, F6
transaction FHTX Common Stock Gift $0 -4.37K -6.49% $0.00 63K Feb 17, 2023 Direct F7
transaction FHTX Common Stock Gift $0 +4.37K +0.98% $0.00 449K Feb 17, 2023 See Footnote F7, F8
transaction FHTX Common Stock Other $0 -185K -29.19% $0.00 449K Feb 17, 2023 See Footnote F9, F10
transaction FHTX Common Stock Other $0 +185K +70.12% $0.00 449K Feb 17, 2023 See Footnote F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported late due to administrative error.
F2 On February 10, 2022, the Reporting Person transferred 123,479 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration.
F3 Consists of 300,000 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 148,704 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
F4 Transfer of assets between the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, and the Reporting Person.
F5 The reported holdings include 40,000 shares of the Issuer's Common Stock acquired by the Reporting Person through an option exercise reported on Form 4 on September 19, 2022.
F6 Consists of 295,629 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 148,704 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
F7 On February 17, 2023, the Reporting Person transferred 4,371 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration.
F8 Consists of 295,629 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 153,075 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
F9 Transfer of assets between the the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, and the Adrian H. Gottschalk Living Trust dated September 8, 2009.
F10 Consists of 110,690 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 338,014 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.